Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Li Gobbi

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Journal of Personalized Medicine|August 27, 2025
Single-Center Cross-Sectional Analysis of Patients with RA, SpA, and PsA: Data from the Prescription DatabaseMaurizio Benucci, Francesca Li Gobbi, Emanuele Antonio Maria Cassarà, et al.
Therapeutics and Clinical Risk Management|May 6, 2020
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical DataMaurizio Benucci, Arianna Damiani, Francesca Li Gobbi, et al.
Journal of Personalized Medicine|July 27, 2022
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic DiseaseMaurizio Benucci, Arianna Damiani, Edda Russo, et al.
Journal of Personalized Medicine|June 27, 2024
Evaluation of a New Multiparametric Microdot Array-Based Immunoassay Panel for Systemic Autoimmune Disease DiagnosisMaria Infantino, Francesca Pavia, Valentina Grossi, et al.
Pharmacological Research|July 30, 2022
Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlightedMaurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Current Rheumatology Reviews|February 11, 2015
Can Tocilizumab Decrease Cartilage Oligomeric Matrix Protein Levels and Disease Activity in Patients with Long-Standing Rheumatoid Arthritis?Maurizio Benucci, Francesca Meacci, Mariangela Manfredi, et al.
Current Rheumatology Reviews|January 21, 2015
Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis?Maurizio Benucci, Francesca Meacci, Mariangela Manfredi, et al.
Biologics : Targets & Therapy|February 13, 2018
Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseasesMaurizio Benucci, Arianna Damiani, Francesca Li Gobbi, et al.
Journal of Personalized Medicine|February 25, 2023
Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1174Maurizio Benucci, Arianna Damiani, Francesca Bandinelli, et al.
Journal of Clinical Medicine|March 28, 2024
Real-Life Comparison of Four JAK Inhibitors in Rheumatoid Arthritis (ELECTRA-<i>i</i> Study)Maurizio Benucci, Francesca Li Gobbi, Arianna Damiani, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Journal of Personalized Medicine|August 27, 2025
Single-Center Cross-Sectional Analysis of Patients with RA, SpA, and PsA: Data from the Prescription DatabaseMaurizio Benucci, Francesca Li Gobbi, Emanuele Antonio Maria Cassarà, et al.
Therapeutics and Clinical Risk Management|May 6, 2020
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical DataMaurizio Benucci, Arianna Damiani, Francesca Li Gobbi, et al.
Journal of Personalized Medicine|July 27, 2022
Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic DiseaseMaurizio Benucci, Arianna Damiani, Edda Russo, et al.
Journal of Personalized Medicine|June 27, 2024
Evaluation of a New Multiparametric Microdot Array-Based Immunoassay Panel for Systemic Autoimmune Disease DiagnosisMaria Infantino, Francesca Pavia, Valentina Grossi, et al.
Pharmacological Research|July 30, 2022
Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlightedMaurizio Benucci, Arianna Damiani, Maria Infantino, et al.
Current Rheumatology Reviews|February 11, 2015
Can Tocilizumab Decrease Cartilage Oligomeric Matrix Protein Levels and Disease Activity in Patients with Long-Standing Rheumatoid Arthritis?Maurizio Benucci, Francesca Meacci, Mariangela Manfredi, et al.
Current Rheumatology Reviews|January 21, 2015
Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis?Maurizio Benucci, Francesca Meacci, Mariangela Manfredi, et al.
Biologics : Targets & Therapy|February 13, 2018
Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseasesMaurizio Benucci, Arianna Damiani, Francesca Li Gobbi, et al.
Journal of Personalized Medicine|February 25, 2023
Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1174Maurizio Benucci, Arianna Damiani, Francesca Bandinelli, et al.
Journal of Clinical Medicine|March 28, 2024
Real-Life Comparison of Four JAK Inhibitors in Rheumatoid Arthritis (ELECTRA-<i>i</i> Study)Maurizio Benucci, Francesca Li Gobbi, Arianna Damiani, et al.
Pageof 7